FCGY yields 2000000.00% · MRK yields 2.76%● Live data
📍 FCGY pulled ahead of the other in Year 1
Combined, FCGY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FCGY + MRK for your $10,000?
Forecastagility Corporation provides legacy application migration solutions to corporate clients in the United States and internationally. The company develops toolsets that migrate RPG and COBOL applications written for the IBM i-AS/400 environment to open platforms, such as Windows, Linux, or UNIX; and toolsets and services to modernize green screen applications for AS/400 and Mainframe environments. Its products include BABYi, a standard edition developer toolset and application server environment to migrate AS/400 RPG and COBOL applications to Windows; and BABY36 developer toolset, a suite of compilers, utilities, and operating system services that allow applications to be rehosted at the source code level, and recompiled and executed on the target platform. The company's products also comprise Infinite i, a suite of compilers, utilities, and operating system services that allow applications and programs to be migrated at the source code level, recompiled, and executed on the target platform; Infinite36 that migrates IBM System/36 RPG and COBOL applications to Windows, Linux, or UNIX; Infinite Cloud that create graphical screens from IBM i/AS400 green screens; and Infinite I Database Migration Tool for DB2 for IBM I (DB2/400) that enables to migrate IBM I, iSeries, and AS/400 data to Oracle or MS SQL environment. In addition, it offers migration and GUI creation services. The company was formerly known as Infinite Software Corporation and changed its name to Forecastagility Corporation in June 2019. Forecastagility Corporation was founded in 1975 and is based in Irvine, California.
Full FCGY Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.